2017
DOI: 10.2174/1389200217666161013090610
|View full text |Cite
|
Sign up to set email alerts
|

Bacteria From Marine Sponges: A Source of New Drugs

Abstract: In this review, we attempt to report the latest studies regarding capability of bacteria from sponges as producers of bioactive metabolite. Moreover, these sponge associated bacteria are an important source of different enzymes of industrial significance. In present review, we will address some novel approaches for discovering marine metabolites from bacteria that have the greatest potential to be used in clinical treatments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
47
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 65 publications
(48 citation statements)
references
References 0 publications
0
47
0
1
Order By: Relevance
“…Illustrative of the importance of symbionts to marine drug discovery, some of these anti-tumorigenic compounds are now suspected to originate from the marine invertebrates symbiotic bacteria, rather than the host itself [8,19,34]. For example, this is true of the anti-tumorigenic drug Yondelis ® (Figrue 1), approved in 2007 for the treatment of ovarian cancer and tissue sarcomas [62].…”
Section: Yondelis ® Smenamides and Smenothiazoles: Compounds With mentioning
confidence: 99%
See 3 more Smart Citations
“…Illustrative of the importance of symbionts to marine drug discovery, some of these anti-tumorigenic compounds are now suspected to originate from the marine invertebrates symbiotic bacteria, rather than the host itself [8,19,34]. For example, this is true of the anti-tumorigenic drug Yondelis ® (Figrue 1), approved in 2007 for the treatment of ovarian cancer and tissue sarcomas [62].…”
Section: Yondelis ® Smenamides and Smenothiazoles: Compounds With mentioning
confidence: 99%
“…Those microbes which have formed symbiotic relationships with a marine invertebrate, like a sponge or coral, have often developed further secondary metabolites, which also protect their hosts from pathogens [86,87]. This combination of self and host protection has selected for a huge range of secondary metabolites isolated from marine symbionts that are reported to have anti-microbial or anti-pathogenic properties [8,19].…”
Section: Yondelis ® Smenamides and Smenothiazoles: Compounds With mentioning
confidence: 99%
See 2 more Smart Citations
“…Nowadays, marine sponges represent a new and very exciting biotechnology approach to explore a large reservoir of secondary metabolites and associated bacterial communities that produce biomolecules with important applications in health and industry (Bibi et al 2017, Calcabrini et al 2017. Considering the biological diversity of sponges existing in the Brazilian coast (Van Soest et al 2012), the potential for discovery of new molecules for health and industry is very large, and this aspect is explored in the manuscript of Araújo et al (2017) by studying the bacterial communities present in three marine sponges species collected in the coast of Rio de Janeiro, Brazil.…”
mentioning
confidence: 99%